A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.

A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.

Post-marketing surveillance of Twotopsplus.

This study will collect clinical data, mainly focused on safety, in Korean population as per the requirement of MFDS for market authorization.

Inclusion Criteria:

• The patient diagnosed with hypertension.
• The patient who is first prescribed and administered Twotopsplus Tab.

Exclusion Criteria:

• The patients who are overreacting to this drug or its components.
• The patients with severe renal impairment.